Lv1
38 积分 2024-07-24 加入
Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years
6个月前
已完结
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
8个月前
已完结
63827 Impact on Multiple Inflammatory Axes Drives a High Level of Efficacy to Upadacitinib: Biomarker Analysis from LEVEL-UP, a Phase 3b/4 Head-to-Head Study with Dupilumab
8个月前
已关闭
皖公网安备34019202002308
